Last Updated on June 22, 2023

Hematological Oncology- Impact Score, Ranking, SJR, h-index, Citescore, Rating, Publisher, ISSN, and Other Important Details


Published By: John Wiley and Sons Ltd

Abbreviation: Hematol. Oncol.




Impact Score

The impact Score or journal impact score (JIS) is equivalent to Impact Factor. The impact factor (IF) or journal impact factor (JIF) of an academic journal is a scientometric index calculated by Clarivate that reflects the yearly mean number of citations of articles published in the last two years in a given journal, as indexed by Clarivate's Web of Science. On the other hand, Impact Score is based on Scopus data.

2.19

SJR

 1.051

h-Index

 50

Rank

 3885

Important Details

Title Hematological Oncology
Standard Abbreviation Hematol. Oncol.
Type of Publication Journal
Discipline Hematology (Q1); Medicine (miscellaneous) (Q1); Cancer Research (Q2); Oncology (Q2)
Impact Score 2.19
SCImago Journal Rank (SJR) 1.051
h-index 50
Overall Rank 3885
Publisher Name John Wiley and Sons Ltd
Publication Country United Kingdom
International Standard Serial Number (ISSN) 10991069, 02780232
Coverage and History 1983-2022
Best Quartile Q1
Total Citations Received
(Last 3 Year)
956

About Hematological Oncology


Hematological Oncology is a journal published by John Wiley and Sons Ltd. This journal covers the area[s] related to Hematology, Medicine (miscellaneous), Cancer Research, Oncology, etc. The coverage history of this journal is as follows: 1983-2022. The rank of this journal is 3885. This journal's impact score, h-index, and SJR are 2.19, 50, and 1.051, respectively. The ISSN of this journal is/are as follows: 10991069, 02780232.

The best quartile of Hematological Oncology is Q1. This journal has received a total of 956 citations during the last three years (Preceding 2022).


Hematological Oncology Impact Score 2022-2023


The latest impact score (IS) of the Hematological Oncology is 2.19. It is computed in the year 2023 as per its definition and based on Scopus data. 2.19

It is decreased by a factor of around 0.78, and the percentage change is -26.26% compared to the preceding year 2021, indicating a falling trend.

The impact score (IS), also denoted as the Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Prediction of Hematological Oncology Impact Score 2023


Impact Score 2022 of Hematological Oncology is 2.19. If a similar downward trend continues, IS may decrease in 2023 as well.


Impact Score Graph


Check below the Impact Score trends of Hematological Oncology. This is based on Scopus data.


Year Impact Score (IS)
2023/2024 Coming Soon
2022 2.19
2021 2.97
2020 2.65
2019 2.04
2018 1.66
2017 1.74
2016 1.46
2015 2.22
2014 2.29

Hematological Oncology h-index


  Table Setting

The h-index of Hematological Oncology is 50. By definition of the h-index, this journal has at least 50 published articles with more than 50 citations.

What is h-index?

The h-index (also known as the Hirsch index or Hirsh index) is a scientometric parameter used to evaluate the scientific impact of the publications and journals. It is defined as the maximum value of h such that the given Journal has published at least h papers and each has at least h citations.




Hematological Oncology ISSN


The International Standard Serial Number (ISSN) of Hematological Oncology is/are as follows: 10991069, 02780232.

The ISSN is a unique 8-digit identifier for a specific publication like Magazine or Journal. The ISSN is used in the postal system and in the publishing world to identify the articles that are published in journals, magazines, newsletters, etc. This is the number assigned to your article by the publisher, and it is the one you will use to reference your article within the library catalogues.

ISSN code (also called as "ISSN structure" or "ISSN syntax") can be expressed as follows: NNNN-NNNC
Here, N is in the set {0,1,2,3...,9}, a digit character, and C is in {0,1,2,3,...,9,X}

Table Setting

Hematological Oncology Ranking and SCImago Journal Rank (SJR)


The Hematological Oncology is ranked 3885 among 27955 Journals, Conferences, and Book Series. As per SJR, this journal is ranked 1.051.

SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.


Hematological Oncology Publisher


Table Setting

The publisher of Hematological Oncology is John Wiley and Sons Ltd. The publishing house of this journal is located in the United Kingdom. Its coverage history is as follows: 1983-2022.


Call For Papers (CFPs)


Please check the official website of this journal to find out the complete details and Call For Papers (CFPs).


Abbreviation


The International Organization for Standardization 4 (ISO 4) abbreviation of Hematological Oncology is Hematol. Oncol.. ISO 4 is an international standard which defines a uniform and consistent system for the abbreviation of serial publication titles, which are published regularly. The primary use of ISO 4 is to abbreviate or shorten the names of scientific journals using the technique of List of Title Word Abbreviations (LTWA).

As ISO 4 is an international standard, the abbreviation ('Hematol. Oncol.') can be used for citing, indexing, abstraction, and referencing purposes.


How to publish in Hematological Oncology


If your area of research or discipline is related to Hematology, Medicine (miscellaneous), Cancer Research, Oncology, etc., please check the journal's official website to understand the complete publication process.


Acceptance Rate


There are several factors that influence the acceptance rate of any academic journal. Here are some critical parameters that are considered while calculating the acceptance rate:

  • Interest/demand of researchers/scientists for publishing in a specific journal/conference.
  • The complexity of the peer review process and timeline.
  • Time taken from draft submission to final publication.
  • Number of submissions received and acceptance slots
  • And Many More.

The simplest way to find out the acceptance rate or rejection rate of a Journal/Conference is to check with the journal's/conference's editorial team through emails or through the official website.



Frequently Asked Questions (FAQ)


What is the impact score of Hematological Oncology?

The latest impact score of Hematological Oncology is 2.19. It is computed in the year 2023.


What is the h-index of Hematological Oncology?

The latest h-index of Hematological Oncology is 50. It is evaluated in the year 2023.


What is the SCImago Journal Rank (SJR) of Hematological Oncology?

The latest SCImago Journal Rank (SJR) of Hematological Oncology is 1.051. It is calculated in the year 2023.


What is the ranking of Hematological Oncology?

The latest ranking of Hematological Oncology is 3885. This ranking is among 27955 Journals, Conferences, and Book Series. It is computed in the year 2023.


Who is the publisher of Hematological Oncology?

Hematological Oncology is published by John Wiley and Sons Ltd. The publication country of this journal is United Kingdom.


What is the abbreviation of Hematological Oncology?

This standard abbreviation of Hematological Oncology is Hematol. Oncol..


Is "Hematological Oncology" a Journal, Conference or Book Series?

Hematological Oncology is a journal published by John Wiley and Sons Ltd.


What is the scope of Hematological Oncology?

The scope of Hematological Oncology is as follows:

  • Hematology
  • Medicine (miscellaneous)
  • Cancer Research
  • Oncology

For detailed scope of Hematological Oncology, check the official website of this journal.


What is the ISSN of Hematological Oncology?

The International Standard Serial Number (ISSN) of Hematological Oncology is/are as follows: 10991069, 02780232.


What is the best quartile for Hematological Oncology?

The best quartile for Hematological Oncology is Q1.


What is the coverage history of Hematological Oncology?

The coverage history of Hematological Oncology is as follows 1983-2022.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/
  • Issn.org, https://www.issn.org/
  • Scopus, https://www.scopus.com/

Note: The impact score shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.


Impact Score, SJR, h-Index, and Other Important metrics of These Journals, Conferences, and Book Series


Journal/Conference/Book Title Type Publisher Ranking SJR h-index Impact Score
Journal of Academic Ethics Journal Springer Netherlands 8920 26 2.28
Business: Theory and Practice Journal Vilnius Gediminas Technical University 13414 21 2.47
Journal of Competition Law and Economics Journal Oxford University Press 14815 29 0.72
Materials Research Journal Universidade Federal de Sao Carlos 14791 65 1.62
Discourse Journal Routledge 6621 59 2.11
International Journal of Parallel, Emergent and Distributed Systems Journal Taylor and Francis Ltd. 15843 23 1.28
Canadian Journal of Education Journal Canadian Society for the Study of Education (CSSE) 17961 41 0.39
Tekstilec Trade Journal Faculty of Natural Sciences and Engineering, Tekstilec 19217 14 0.73
Proceedings of the Technical Association of the Graphic Arts, TAGA Conference And Proceedings Technical Association of the Graphic 30903 8 0.00
Proceedings of the International Semiconductor Conference, CAS Conference And Proceedings Institute of Electrical and Electronics Engineers Inc. 25734 16 0.00

Check complete list




Hematological Oncology Impact Score (IS) Trend

Table: Impact Score

Year Impact Score (IS)
2023/2024 Updated Soon
2022 2.19
2021 2.97
2020 2.65
2019 2.04
2018 1.66
2017 1.74
2016 1.46
2015 2.22
2014 2.29



Top Journals/Conferences in Hematology

Ca-A Cancer Journal for Clinicians
Wiley-Blackwell | United States

Annals of Oncology
Elsevier Ltd. | United Kingdom

Journal of Hematology and Oncology
BioMed Central Ltd. | United Kingdom

Blood
Elsevier BV | United States

Lancet Haematology,The
Lancet Publishing Group | United Kingdom

Blood Cancer Journal
Nature Publishing Group | United States

Leukemia
Nature Publishing Group | United Kingdom

Journal of Thrombosis and Haemostasis
Wiley-Blackwell Publishing Ltd | United Kingdom

Blood advances
Elsevier BV | United States

American Journal of Hematology
Wiley-Liss Inc. | United States

Blood Reviews
Churchill Livingstone | United States

Journal of the National Cancer Center
Chinese National Cancer Center | China

Haematologica
Ferrata Storti Foundation | Italy

Experimental Hematology and Oncology
BioMed Central Ltd. | United Kingdom

Radiotherapy and Oncology
Elsevier Ireland Ltd | Ireland

See All

Top Journals/Conferences in Medicine (miscellaneous)

New England Journal of Medicine
Massachussetts Medical Society | United States

Nature Medicine
Nature Publishing Group | United Kingdom

MMWR Recommendations and Reports
Centers for Disease Control and Prevention (CDC) | United States

Nature Reviews Drug Discovery
Nature Publishing Group | United Kingdom

Nature Reviews Immunology
Nature Publishing Group | United Kingdom

Morbidity and Mortality Weekly Report
Department of Health and Human Services | United States

Lancet, The
Elsevier Ltd. | United Kingdom

Physiological Reviews
American Physiological Society | United States

MMWR supplements
Epidemiology Program Office | United States

Annals of Oncology
Elsevier Ltd. | United Kingdom

Nature Reviews Disease Primers
Nature Publishing Group | United Kingdom

Current Protocols in Bioinformatics
John Wiley & Sons Inc. | United States

Journal of Clinical Oncology
Lippincott Williams and Wilkins Ltd. | United States

Annual Review of Public Health
Annual Reviews Inc. | United States

Nature Reviews Methods Primers
Springer Nature | United States

See All

Top Journals/Conferences in Cancer Research

Nature Reviews Cancer
Nature Publishing Group | United Kingdom

Cancer Cell
Cell Press | United States

Cell Host and Microbe
Cell Press | United States

Journal of Clinical Oncology
Lippincott Williams and Wilkins Ltd. | United States

Nature Cancer
| United States

Molecular Cancer
BioMed Central Ltd. | United Kingdom

JAMA Oncology
American Medical Association | United States

Signal Transduction and Targeted Therapy
Springer Nature | United Kingdom

Journal of Hematology and Oncology
BioMed Central Ltd. | United Kingdom

Journal of the National Cancer Institute
Oxford University Press | United Kingdom

Neuro-Oncology
Oxford University Press | United Kingdom

Clinical Cancer Research
American Association for Cancer Research Inc. | United States

Annual Review of Cancer Biology
Annual Reviews Inc. | United States

Drug Resistance Updates
Churchill Livingstone | United States

Trends in Cancer
Cell Press | United States

See All

Top Journals/Conferences in Oncology

Ca-A Cancer Journal for Clinicians
Wiley-Blackwell | United States

Nature Reviews Cancer
Nature Publishing Group | United Kingdom

Nature Reviews Clinical Oncology
Nature Publishing Group | United Kingdom

Cancer Cell
Cell Press | United States

Lancet Oncology, The
Elsevier Ltd. | United Kingdom

Annals of Oncology
Elsevier Ltd. | United Kingdom

Journal of Clinical Oncology
Lippincott Williams and Wilkins Ltd. | United States

Nature Cancer
| United States

Molecular Cancer
BioMed Central Ltd. | United Kingdom

JAMA Oncology
American Medical Association | United States

Cancer Discovery
American Association for Cancer Research Inc. | United States

Lancet Regional Health - Europe, The
Elsevier Ltd. | United Kingdom

Journal of Hematology and Oncology
BioMed Central Ltd. | United Kingdom

Journal of Thoracic Oncology
International Association for the Study of Lung Cancer | United States

Journal of the National Cancer Institute
Oxford University Press | United Kingdom

See All